Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases
Cellular Signalling · 2026-10 · 146 · 112654
DOI: 10.1016/j.cellsig.2026.112654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Xuan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, 3',5'-Cyclic-AMP Phosphodiesterases. Die Arbeit nennt 95 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Technology Research and Development Program of Shandong Province, Shandong First Medical University.
Abstract (Originalsprache)
Phosphodiesterases (PDEs) constitute a superfamily of enzymes comprising 11 distinct families that hydrolyze cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), thereby precisely regulating the spatiotemporal dynamics of intracellular cyclic nucleotides. Among these PDEs, PDE8 is distinguished by its high affinity and specificity for cAMP and exerts diverse biological effects. The PDE8 family comprises two genes, Pde8a and Pde8b, which are widely distributed throughout the brain and are expressed in both neuronal and glial cells. The widespread distribution of PDE8 in the brain suggests its involvement in roles of the central nervous system (CNS). In this context, dysregulation of PDE8 has been implicated in the pathogenesis of several CNS diseases, including neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This review aimed to enhance the understanding of the role of PDE8 in the mechanisms underlying neurodegenerative diseases, while providing a theoretical foundation and potential avenues for developing novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
- Department of Neurobiology, School of Basic Medical Sciences, National Institute on Drug Dependence, Peking University, Beijing 100191, China.
- Qingdao Medical College, Qingdao University, Qingdao 266071, China.
- Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Electro…
- Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China. Electronic address: tywanghao_2005@163.com.
Förderung
- National Natural Science Foundation of China
- Key Technology Research and Development Program of Shandong Province
- Shandong First Medical University
Zitieren
APA
Zhao, X., Fu, Y. T., Qiu, N. Z., Pan, Y. X., Zhang, H. T., & Wang, H. (2026). Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases. Cellular Signalling, 146, 112654. https://doi.org/10.1016/j.cellsig.2026.112654
Vancouver
Zhao X, Fu YT, Qiu NZ, Pan YX, Zhang HT, Wang H. Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases. Cellular Signalling. 2026;146:112654. doi:10.1016/j.cellsig.2026.112654
BibTeX
@article{Zhao2026,
author = {Zhao, Xuan and Fu, Yi-Ting and Qiu, Nian-Zhuang and Pan, Yu-Xuan and Zhang, Han-Ting and Wang, Hao},
title = {Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112654},
doi = {10.1016/j.cellsig.2026.112654}
}
EUVIMED